New model predicts growth hormone therapy response in children with short stature
News-Medical reports on a retrospective, single-center study of 91 prepubertal Korean children with idiopathic short stature on growth hormone therapy. Mean height percentile rose from 1.26 to 9.16, with wide individual variation. Higher BMI, lower IGFBP-3 and shorter paternal height were associated with greater predicted response. A web tool, GrowCast, was built but is not yet validated; larger prospective studies are needed.
Why it matters: Relevant to referring clinicians and parents in Maryland who discuss growth hormone therapy for children with idiopathic short stature.
A summary of another publisher's reporting, written with AI and checked automatically against the story. The reporting belongs to news-medical.net. October 5, 2026.